161 related articles for article (PubMed ID: 3228706)
1. Induction of erythroid differentiation by the anthracycline antitumor antibiotic pyrromycin.
Steinheider G; Schaefer A; Westendorf J; Marquardt H
Cell Biol Toxicol; 1988 Mar; 4(1):123-33. PubMed ID: 3228706
[TBL] [Abstract][Full Text] [Related]
2. Induction of erythroid differentiation by the anthracycline antitumor antibiotics, aclacinomycin A, musettamycin and marcellomycin.
Steinheider G; Westendorf J; Marquardt H
Leuk Res; 1986; 10(10):1233-9. PubMed ID: 3464812
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
Schaefer A; Dahle M; Radenz G; Steinheider G; Marquardt H
Leukemia; 1991 Feb; 5(2):95-100. PubMed ID: 2020200
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
Schwartz EL; Sartorelli AC
Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of amino acid uptake and incorporation into proteins in Friend erythroleukemia cells by the anthracycline antitumor antibiotic aclacinomycin A.
Schaefer A; Boldt J; Westendorf J; Steinheider G; Marquardt H
Biochem Pharmacol; 1988 Apr; 37(7):1377-82. PubMed ID: 3162677
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.
Morin MJ; Sartorelli AC
Cancer Res; 1984 Jul; 44(7):2807-12. PubMed ID: 6327026
[TBL] [Abstract][Full Text] [Related]
7. Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells.
Aries A; Trentesaux C; Ottolenghi S; Jardillier JC; Jeannesson P; Doubeikovski A
Blood; 1996 Apr; 87(7):2885-90. PubMed ID: 8639908
[TBL] [Abstract][Full Text] [Related]
8. Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc and c-myb mRNA levels.
Schaefer A; Dressel A; Lingelbach K; Schmidt CA; Steinheider G; Marquardt H
Leukemia; 1992 Aug; 6(8):828-33. PubMed ID: 1640736
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
[TBL] [Abstract][Full Text] [Related]
10. Induction of chromosomal aberrations by the anthracycline antitumor antibiotics N,N-dimethyldaunomycin and aclacinomycin A.
Steinheider G; Westendorf J; Marquardt H
Experientia; 1987 May; 43(5):586-8. PubMed ID: 3472901
[TBL] [Abstract][Full Text] [Related]
11. Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells.
Morceau F; Aries A; Lahlil R; Devy L; Jardillier JC; Jeannesson P; Trentesaux C
Biochem Pharmacol; 1996 Mar; 51(6):839-45. PubMed ID: 8602880
[TBL] [Abstract][Full Text] [Related]
12. Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression.
Jeannesson P; Lahlil R; Chenais B; Devy L; Gillet R; Aries A; Morceau F; Trentesaux C
Leuk Lymphoma; 1997 Aug; 26(5-6):575-87. PubMed ID: 9389364
[TBL] [Abstract][Full Text] [Related]
13. Effects of several anthracycline antitumor antibiotics on the transcriptional activity of isolated nucleoli.
DuVernay VH; Crooke ST
J Antibiot (Tokyo); 1980 Sep; 33(9):1048-53. PubMed ID: 6160136
[TBL] [Abstract][Full Text] [Related]
14. Deoxyribonucleic acid binding studies on several new anthracycline antitumor antibiotics. Sequence preference and structure--activity relationships of marcellomycin and its analogues as compared to adriamycin.
DuVernay VH; Pachter JA; Crooke ST
Biochemistry; 1979 Sep; 18(18):4024-30. PubMed ID: 486409
[TBL] [Abstract][Full Text] [Related]
15. Tumorigenicity in vivo and induction of mutagenesis and DNA repair in vitro by aclacinomycin A and marcellomycin: structure-activity relationship and predictive value of short-term tests.
Westendorf J; Marquardt H; Ketkar MB; Mohr U; Marquardt H
Cancer Res; 1983 Nov; 43(11):5248-51. PubMed ID: 6352017
[TBL] [Abstract][Full Text] [Related]
16. Induction of leukemia cell differentiation by chemotherapeutic agents.
Schwartz EL; Ishiguro K; Sartorelli AC
Adv Enzyme Regul; 1983; 21():3-20. PubMed ID: 6400065
[TBL] [Abstract][Full Text] [Related]
17. Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line.
Burres NS; Myers MT; Sartorelli AC
Cancer Biochem Biophys; 1988 Jul; 10(1):47-57. PubMed ID: 3224331
[TBL] [Abstract][Full Text] [Related]
18. Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells.
Nyoung MN; Trentesaux C; Aries A; Carpentier Y; Jardillier JC; Gorisse MC; Jeannesson P
Anticancer Res; 1994; 14(3A):1203-8. PubMed ID: 8074473
[TBL] [Abstract][Full Text] [Related]
19. Studies on aclacinomycin A resistance in mouse lymphoblastoma.
Nishimura T; Suzuki H; Muto K; Tanaka Y; Tanaka N
J Antibiot (Tokyo); 1980 Jul; 33(7):737-43. PubMed ID: 6931828
[TBL] [Abstract][Full Text] [Related]
20. Nuclear transcription factor GATA-1 is activated during aclacinomycin-induced erythroid differentiation.
Gillet R; Bobichon H; Trentesaux C
Biol Cell; 2002 Sep; 94(4-5):267-73. PubMed ID: 12489695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
